MEMORY MANINGA, Lusaka
SONDASHI Formula (SF2000) inventor Ludwig Sondashi has called on Government to release funds for the next phase of clinical trials after the completion of phase one.
Phase one of the clinical trials were meant to determine the safety and tolerability of SF2000 before the medicine can be allowed to be used as a cure for HIV and AIDS.
The next phase which will test the efficacy of the drug is expected to start soon.
Speaking on behalf of Dr Sondashi in Lusaka on Tuesday, Innocent Sondashi said it is unfortunate that the progress in the research and development of the formula is slow, adding that it is important that serious introspection is done.
“I remain fully committed to ensuring that this medicine is subjected to scientific evaluation, but you would also agree with me that the 16 years it has taken to allow the safety and tolerability trials is a long time and this requires serious introspection,” Dr Sondashi said.
He said it is important for Government to support the next phase of the clinical trials as this would help to determine the effectiveness of the medicine before patients can begin using it.
“I implore Government to take keen interest in the efficacy trials that will soon commence. Despite the many projects that Government is undertaking, these trials are important as they border on the health of the people,” he said.
Dr Sondashi said partnering with Government is important as the medicine would be made available cheaply if the efficacy is authenticated.